John Brandsema, MD

Articles

Using Small Molecule Treatment for SMA Management

July 17, 2021

Experts in pediatric neurology share insights on the role of small molecule treatment for SMA through the recent FDA approval of risdiplam and discuss factors to consider when tailoring therapy for individual patients.